Evidence map›Paper›PMID 19488770›Full record

ArticleInternational journal of colorectal disease2009

Quality management in rectal carcinoma: what is feasible?

Susanne Merkel, Daniela Klossek, Jonas Göhl, Thomas Papadopoulos, Werner Hohenberger, Paul Hermanek

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Practicability of quality goals for the treatment of rectal cancer.International journal of colorectal disease · 2010
    Article
  10. [Tumors of the lower gastrointestinal tract : Indication and extent of lymph node dissection].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susanne MerkelDepartment of Surgery, University Hospital Erlangen, Erlangen, Germany. susanne.merkel@uk-erlangen.de
Daniela Klossek
Jonas Göhl
Thomas Papadopoulos
Werner Hohenberger
Paul Hermanek

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA cohort study was carried out to analyse quality indicators in the diagnosis and treatment of rectal carcinoma.

methodsA total of 2,470 patients with rectal carcinoma treated between 1985 and 2007 at the Department of Surgery, University of Erlangen, were analysed and compared within four time intervals.

resultsMost of the indicators analysed from 2004 to 2007 fulfilled the defined target values. The indicators for process quality of surgical treatment and the surrogate indicators of outcome quality in surgery showed excellent results. Comparing this to previous data, it displays the new developments such as introduction of multimodal treatment for high-risk patients. While the rate of locoregional recurrences decreased, no significant improvement in survival was found.

conclusionsCareful analysis of quality indicators is important for both quality management and comparison of treatment results. The progress in diagnosis and treatment requires a continuous update of definitions and target values.

Indexed as

AdultAgedAged, 80 and overCarcinomaChemotherapy, AdjuvantDigestive System Surgical ProceduresFeasibility StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoadjuvant TherapyNeoplasm Recurrence, LocalOutcome and Process Assessment, Health CareProspective Studies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.